Vaccine leader signs deal for 1 billion Covid-19 doses a year
Posted by
www.biotecnika.org
Moderna's experimental shot induces the body's own cells to make
virus-like proteins that stimulate an immune response and prepare for
an actual infection. It was one of the first proposed coronavirus
vaccines to enter human trials. The company said it plans to begin the
next phase of studies this quarter.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/vaccine-leader-signs-deal-for-1-billion-covid-19-doses-a-year/articleshow/75497484.cms
Subscribe to:
Post Comments (Atom)
Post a Comment